175 related articles for article (PubMed ID: 11834140)
1. Effect of glycyrrhetinic acid on 11 beta-hydroxysteroid dehydrogenase activity in normotensive and hypertensive subjects.
van Uum SH; Walker BR; Hermus AR; Sweep CG; Smits P; de Leeuw PW; Lenders JW
Clin Sci (Lond); 2002 Feb; 102(2):203-11. PubMed ID: 11834140
[TBL] [Abstract][Full Text] [Related]
2. Short-term cortisol infusion in the brachial artery, with and without inhibiting 11 beta-hydroxysteroid dehydrogenase, does not alter forearm vascular resistance in normotensive and hypertensive subjects.
van Uum SH; Hermus AR; Sweep CG; Walker BR; Ross HA; de Leeuw PW; Lenders JW
Eur J Clin Invest; 2002 Dec; 32(12):874-81. PubMed ID: 12534445
[TBL] [Abstract][Full Text] [Related]
3. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
Best R; Walker BR
Clin Endocrinol (Oxf); 1997 Aug; 47(2):231-6. PubMed ID: 9302399
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans.
Sobieszczyk P; Borlaug BA; Gornik HL; Knauft WD; Beckman JA
Clin Sci (Lond); 2010 Aug; 119(10):437-42. PubMed ID: 20515440
[TBL] [Abstract][Full Text] [Related]
5. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
6. Acute intrarenal administration of cortisol has no effect on renal blood flow in hypertensive individuals.
van Uum SH; Houben AJ; Hermus AR; Kroon AA; Walker BR; Sweep CG; Smits P; de Leeuw PW; Lenders JW
J Hypertens; 2002 Nov; 20(11):2275-83. PubMed ID: 12409967
[TBL] [Abstract][Full Text] [Related]
7. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
8. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers.
MacKenzie MA; Hoefnagels WH; Jansen RW; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1990 Jun; 70(6):1637-43. PubMed ID: 2161425
[TBL] [Abstract][Full Text] [Related]
9. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
Stewart PM; Murry BA; Mason JI
J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
[TBL] [Abstract][Full Text] [Related]
10. The role of 11 beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension.
van Uum SH; Hermus AR; Smits P; Thien T; Lenders JW
Cardiovasc Res; 1998 Apr; 38(1):16-24. PubMed ID: 9683905
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria.
Serra A; Uehlinger DE; Ferrari P; Dick B; Frey BM; Frey FJ; Vogt B
J Am Soc Nephrol; 2002 Jan; 13(1):191-196. PubMed ID: 11752037
[TBL] [Abstract][Full Text] [Related]
12. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR
Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
[TBL] [Abstract][Full Text] [Related]
13. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
[TBL] [Abstract][Full Text] [Related]
14. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure.
Benediktsson R; Calder AA; Edwards CR; Seckl JR
Clin Endocrinol (Oxf); 1997 Feb; 46(2):161-6. PubMed ID: 9135697
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.
Walker BR; Connacher AA; Webb DJ; Edwards CR
Clin Sci (Lond); 1992 Aug; 83(2):171-8. PubMed ID: 1327632
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
Walker BR; Andrew R; MacLeod KM; Padfield PL
Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
[TBL] [Abstract][Full Text] [Related]
17. Serum cortisol/cortisone ratio after Synacthen stimulation.
Vogeser M; Zachoval R; Jacob K
Clin Biochem; 2001 Jul; 34(5):421-5. PubMed ID: 11522281
[TBL] [Abstract][Full Text] [Related]
18. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
Stewart PM; Whorwood CB; Walker BR
Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
[TBL] [Abstract][Full Text] [Related]
19. A non-isotopic method for estimating 11 beta hydroxysteroid dehydrogenase activity in vivo.
Bayly GR; Bartlett WA; Jones AF
Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():521-6. PubMed ID: 9293306
[TBL] [Abstract][Full Text] [Related]
20. Urinary cortisol to cortisone metabolites in hypertensive obese children.
Csábi GY; Juricskay S; Molnár D
J Endocrinol Invest; 2000; 23(7):435-9. PubMed ID: 11005267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
